Cargando…
In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054139/ https://www.ncbi.nlm.nih.gov/pubmed/33862586 http://dx.doi.org/10.1016/j.ebiom.2021.103334 |
| _version_ | 1783680246097117184 |
|---|---|
| author | Mohan, H. Guzman Lenis, M. Laurette, E.Y. Tejada, O. Sanghvi, T. Leung, K.-Y. Cahill, L.S. Sled, J.G. Delgado-Olguín, P. Greene, N.D.E. Copp, A.J. Serghides, L. |
| author_facet | Mohan, H. Guzman Lenis, M. Laurette, E.Y. Tejada, O. Sanghvi, T. Leung, K.-Y. Cahill, L.S. Sled, J.G. Delgado-Olguín, P. Greene, N.D.E. Copp, A.J. Serghides, L. |
| author_sort | Mohan, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8054139 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80541392021-04-22 In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” Mohan, H. Guzman Lenis, M. Laurette, E.Y. Tejada, O. Sanghvi, T. Leung, K.-Y. Cahill, L.S. Sled, J.G. Delgado-Olguín, P. Greene, N.D.E. Copp, A.J. Serghides, L. EBioMedicine Letter Elsevier 2021-04-13 /pmc/articles/PMC8054139/ /pubmed/33862586 http://dx.doi.org/10.1016/j.ebiom.2021.103334 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter Mohan, H. Guzman Lenis, M. Laurette, E.Y. Tejada, O. Sanghvi, T. Leung, K.-Y. Cahill, L.S. Sled, J.G. Delgado-Olguín, P. Greene, N.D.E. Copp, A.J. Serghides, L. In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title | In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title_full | In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title_fullStr | In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title_full_unstemmed | In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title_short | In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| title_sort | in response to the letter to the editor by romach et al. re our publication “dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054139/ https://www.ncbi.nlm.nih.gov/pubmed/33862586 http://dx.doi.org/10.1016/j.ebiom.2021.103334 |
| work_keys_str_mv | AT mohanh inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT guzmanlenism inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT lauretteey inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT tejadao inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT sanghvit inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT leungky inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT cahillls inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT sledjg inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT delgadoolguinp inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT greenende inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT coppaj inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT serghidesl inresponsetothelettertotheeditorbyromachetalreourpublicationdolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels |